Cited by 376Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesHypothalamic control of reproductive hormones

The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.

Drug Insight: the role of leptin in human physiology and pathophysiology—emerging clinical applications

Brennan, Aoife M, Mantzoros, Christos S·2006·Nature Clinical Practice Endocrinology & Metabolism

Abstract

Leptin is an adipocyte-secreted hormone with a key role in energy homeostasis. Studies in animal models, in humans with congenital complete leptin deficiency, and observational and interventional studies in humans with relative leptin deficiency (lower than normal leptin levels) have all indicated that leptin regulates multiple physiological functions, primarily in states of energy deficiency. This information led to proof-of-concept clinical trials involving leptin administration to individuals with relative or complete leptin deficiency. These conditions include congenital complete leptin deficiency, due to mutations in the leptin gene, and states of relative leptin deficiency including lipoatrophy and some forms of hypothalamic amenorrhea. Leptin, in replacement doses, normalizes neuroendocrine, metabolic and immune function in patients with these conditions, but further clinical studies are required to determine its long-term efficacy and safety. Management of leptin-deficient states with replacement doses of leptin holds promise as a therapeutic option. In addition, elucidation of the mechanisms underlying leptin resistance, which characterizes hyperleptinemic states such as human obesity and diabetes, might provide novel therapeutic targets for these prevalent clinical problems.

Overview

Integrity signals

Registry

Crossref · 10.1038/ncpendmet0196

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 82 references

1 of the 82 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Hollander P et al. (2000) A randomized double-blinded placebo-controlled study to determine the effects of subcutaneous recombinant methionyl human leptin on glycemic control in obese subjects with diet-treated type 2 diabetes mellitus. Abstract from the 60th Scientific Sessions of the American Diabetes Association: 2000 June 9–13; San Antonio, TX, USA
  2. Heiman ML et al. (1997) Leptin inhibition of the hypothalamic–pituitary–adrenal axis in response to stress. Endocrinology 138: 3859–3863 · DOI

Cited by

Sorted by citations

Items 101–200 of 376

Metadata

Authors
Brennan, A. M., & Mantzoros, C. S.
Affiliations
Beth Israel Deaconess Medical Center (US)
Corresponding author
Mantzoros, Christos S
Venue
Nature Clinical Practice Endocrinology & Metabolism
Published
2006-06
Volume
2
Issue
6
Pages
318-327
ISSN
  • 1745-8366 (ISSN-L)
  • 1745-8374
OpenAlex
W2036849525
Cited by
374
References
82
Citations by year
2025: 8 · 2024: 6 · 2023: 17 · 2022: 19 · 2021: 23 · 2020: 27 · 2019: 20 · 2018: 19 · 2017: 28 · 2016: 26 · 2015: 21 · 2014: 27 · 2013: 31 · 2012: 28
FWCI
1.16
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Alexander von Humboldt-Stiftung
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 58785)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
leptin, leptin resistance, leptin deficiency, congenital leptin deficiency, lipoatrophy, hypothalamic amenorrhea, obesity, diabetes mellitus, energy homeostasis, leptin replacement therapy, neuroendocrine function, immune function
MeSH terms
Animals, Energy Metabolism, Humans, Immunity, Models, Biological, Neurosecretory Systems, Obesity, Leptin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review